Edwards Lifesciences Corporation Share Price
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.99 USD | +2.45% |
|
+4.01% | -5.00% |
| Capitalization | 4.67TCr 3.96TCr 3.64TCr 3.44TCr 6.38TCr 4,32100Cr 6.5TCr 43TCr 17TCr 2,09400Cr 18TCr 17TCr 7,38200Cr | P/E ratio 2026 * |
28x | P/E ratio 2027 * | 25.6x |
|---|---|---|---|---|---|
| Enterprise value | 4.2TCr 3.55TCr 3.27TCr 3.1TCr 5.74TCr 3,88300Cr 5.84TCr 38TCr 15TCr 1,88200Cr 16TCr 15TCr 6,63400Cr | EV / Sales 2026 * |
6.29x | EV / Sales 2027 * | 5.52x |
| Free-Float |
89.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +2.45% | ||
| 1 week | +4.01% | ||
| Current month | +1.14% | ||
| 1 month | -3.89% | ||
| 3 months | -3.98% | ||
| 6 months | +8.51% | ||
| Current year | -5.00% |
| 1 week | 77.1 | 81.69 | |
| 1 month | 77.1 | 83.83 | |
| Current year | 74.66 | 87.32 | |
| 1 year | 68.63 | 87.89 | |
| 3 years | 58.93 | 96.12 | |
| 5 years | 58.93 | 131.73 | |
| 10 years | 27.04 | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Scott Ullem
DFI | Director of Finance/CFO | 59 | 01/01/2014 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.45% | +4.01% | +13.23% | -3.64% | 4.56TCr | ||
| +2.05% | +6.15% | +23.18% | -10.53% | 19TCr | ||
| +2.43% | +4.13% | -2.80% | +74.50% | 16TCr | ||
| +0.50% | +2.71% | +4.24% | -23.85% | 14TCr | ||
| +1.28% | +3.95% | -32.47% | +24.14% | 9.43TCr | ||
| +1.46% | +3.02% | -12.88% | -27.51% | 5.04TCr | ||
| +3.06% | +5.92% | +18.92% | -13.07% | 3.34TCr | ||
| +1.99% | +2.02% | +19.70% | -9.74% | 3.34TCr | ||
| +1.51% | -0.33% | +7.14% | +1.18% | 3.26TCr | ||
| +2.74% | +2.43% | +2.11% | +5.87% | 3.13TCr | ||
| Average | +1.78% | +2.90% | +4.04% | +1.73% | 8.13TCr | |
| Weighted average by Cap. | +1.47% | +3.22% | +3.76% | +8.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 667.47Cr 565.41Cr 520.24Cr 492.36Cr 912.5Cr 62TCr 928.53Cr 6.09TCr 2.39TCr 30TCr 2.5TCr 2.45TCr 1,05500Cr | 733.49Cr 621.34Cr 571.7Cr 541.07Cr 1TCr 68TCr 1.02TCr 6.7TCr 2.63TCr 33TCr 2.75TCr 2.69TCr 1,16000Cr |
| Net income | 167.56Cr 141.94Cr 130.6Cr 123.6Cr 229.07Cr 16TCr 233.1Cr 1.53TCr 599.75Cr 7.52TCr 628.54Cr 615.46Cr 26TCr | 182.78Cr 154.83Cr 142.46Cr 134.83Cr 249.88Cr 17TCr 254.27Cr 1.67TCr 654.24Cr 8.2TCr 685.64Cr 671.38Cr 29TCr |
| Net Debt | -473.32Cr -400.95Cr -368.92Cr -349.15Cr -647.09Cr -44TCr -658.45Cr -4.32TCr -1.69TCr -21TCr -1.78TCr -1.74TCr -75TCr | -619.42Cr -524.71Cr -482.79Cr -456.92Cr -846.81Cr -57TCr -861.69Cr -5.65TCr -2.22TCr -28TCr -2.32TCr -2.28TCr -98TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | 80.99 $ | +2.45% | 55,55,159 |
| 16/26/16 | 79.05 $ | +1.09% | 61,92,791 |
| 15/26/15 | 78.20 $ | 0.00% | 51,28,511 |
| 14/26/14 | 78.20 $ | +0.10% | 58,59,782 |
| 13/26/13 | 78.12 $ | +0.32% | 63,03,264 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















